Since PTEN is a major regulating pathway of PI3K/Akt/mTOR signaling, loss of PTEN contributes to the upregulation of this signaling cascade, eventually resulting in enhanced cell proliferation and chemoresistance in AML, CML, and ALL. This evidence concerns the gene PIK3CA and acute myeloid leukemia.